{"id":1392,"date":"2025-06-28T15:34:24","date_gmt":"2025-06-28T15:34:24","guid":{"rendered":"https:\/\/fhucare2.laurent-angeli.fr\/event\/anti-pd-1-amplifies-co-stimulation-in-melanoma-infiltrating-th1-like-foxp3-regulatory-t-cells-to-alleviate-local-immunosuppression-tijc7\/"},"modified":"2025-12-25T19:00:48","modified_gmt":"2025-12-25T18:00:48","slug":"anti-pd-1-amplifies-co-stimulation-in-melanoma-infiltrating-th1-like-foxp3-regulatory-t-cells-to-alleviate-local-immunosuppression-tijc7","status":"publish","type":"post","link":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/event\/anti-pd-1-amplifies-co-stimulation-in-melanoma-infiltrating-th1-like-foxp3-regulatory-t-cells-to-alleviate-local-immunosuppression-tijc7\/","title":{"rendered":"Anti-PD-1 amplifies co-stimulation in melanoma-infiltrating Th1-like Foxp3+ Regulatory T cells to alleviate local immunosuppression TIJC#7"},"content":{"rendered":"<h4><span style=\"color: #000080\"><strong>WEBINAR Transdisciplinary Immunology Journal Club<\/strong><\/span><br \/><strong><span style=\"background-color: #000000;color: #ffcc00\">Anti-PD-1 amplifies co-stimulation in melanoma-infiltrating Th1-like Foxp3+ Regulatory T cells to alleviate local immunosuppression&nbsp;&nbsp;<br \/><\/span><\/strong>Mikha\u00ebl ATTIAS<br \/>Thursday, June 19, 2025 from 5:00 PM to 6:00 PM<br \/><a href=\"https:\/\/docs.google.com\/document\/d\/12VZL8lKAfk_8o8gGYdvyLUUKRkHjj7HKJoB8IiJtab8\/edit?usp=sharing\" target=\"_blank\" rel=\"noopener\"><strong>REGISTRATION<\/strong>&nbsp;here &gt;&gt; to get the ZOOM link!<\/a><\/h4>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Revoir en Replay TIJC#6bis<br \/><strong>HLA class I peptide polymorphisms contribute to class II DQ\u03b20603:DQ\u03b10103 antibody specificity<\/strong> par le Dr C\u00e9dric Usureau<\/p>\n<p>Revoir en Replay TIJC#6<br \/><strong>Evolution of myeloid-mediated immunotherapy resistance in prostate cancer : Lyu A &amp; al. Nature.2025 <\/strong>&nbsp;par le <a href=\"https:\/\/youtu.be\/TsJ6ZqtS6RM?si=UVh1NsbtntY9GfZz&amp;t=3\" target=\"_blank\" rel=\"noopener\">Dr Simon COIBA, disponible ICI<\/a><\/p>\n<\/p>\n<p>Revoir en Replay TIJC#5<br \/><strong>Neoantigen vaccines: a new era of precision medicine in oncology<\/strong>&nbsp;par le <a href=\"https:\/\/youtu.be\/b5qoHiJpHGE\" target=\"_blank\" rel=\"noopener\">Dr Adrien MOUREN, disponible ICI<\/a><\/p>\n<\/p>\n<p>Revoir en Replay TIJC#4<br \/><strong>Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division (Nat Immunol.)<\/strong> par le <a href=\"https:\/\/youtu.be\/zu9ce70MxEA?si=3FY0IdtlLkSEZLWb&amp;t=1\">Dr Matthieu Roulleau Dugage, disponible ICI<br \/><\/a><\/p>\n<\/p>\n<p>Revoir en Replay TIJC#3<br \/><strong>Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis, JExpMed.&nbsp;<br \/><\/strong>With Dr Marie ROBERT.<strong>&nbsp;<a href=\"https:\/\/www.youtube.com\/watch?v=BMAzJP9z-oQ\" target=\"_blank\" rel=\"noopener\">REPLAY HERE !&nbsp;<\/a><\/strong><\/p>\n<\/p>\n<p>Revoir en Replay TIJC#2<br \/><strong>The type 2 cytokine Fc\u2013IL-4 revitalizes exhausted CD8+ T cells against cancer, Nature 2024.&nbsp;<\/strong>P<a href=\"https:\/\/youtu.be\/j6wn-f__GwU?si=NzuWOsK-geE3XuRN\">ar le Dr Fran\u00e7ois-Xavier Danlos, disponible ICI<\/a><\/p>\n<\/p>\n<p>Revoir en Replay TIJC#1<br \/><a href=\"https:\/\/youtu.be\/1k7rr2e4HxQ?si=rfk5Vm8aY4OLnY9f&amp;t=1\"><strong>JAK Inhibitors and Cancer: Friend or Foe?&nbsp;<\/strong>Par le Dr Samuel Bitoun, disponible ICI<\/a><\/p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>WEBINAR Transdisciplinary Immunology Journal ClubAnti-PD-1 amplifies co-stimulation in melanoma-infiltrating Th1-like Foxp3+ Regulatory T cells to alleviate local immunosuppression&nbsp;&nbsp;Mikha\u00ebl ATTIASThursday, June 19, 2025 from 5:00 PM to 6:00 PMREGISTRATION&nbsp;here &gt;&gt; to get the ZOOM link! &nbsp; &nbsp; Revoir en Replay TIJC#6bisHLA class I peptide polymorphisms contribute to class II DQ\u03b20603:DQ\u03b10103 antibody specificity par le Dr C\u00e9dric [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1393,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"event_date":"Thursday, June 19, 2025","event_location":"online webinar","event_time":"from 5:00 PM to 6:00 PM","footnotes":""},"categories":[10],"tags":[],"class_list":["post-1392","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-event"],"_links":{"self":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1392","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/comments?post=1392"}],"version-history":[{"count":2,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1392\/revisions"}],"predecessor-version":[{"id":2380,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1392\/revisions\/2380"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media\/1393"}],"wp:attachment":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media?parent=1392"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/categories?post=1392"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/tags?post=1392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}